HPDL deficiency causes a neuromuscular disease by impairing the mitochondrial respiration
Yu Sun,Xiujuan Wei,Fang Fang,Yiping Shen,Haiyan Wei,Jiuwei Li,Xianglai Ye,Yongkun Zhan,Xiantao Ye,Xiaomin Liu,Wei Yang,Yuhua Li,Xiangju Geng,Xuelin Huang,Yiyan Ruan,Zailong Qin,Shang Yi,Jianxin Lyu,Hezhi Fang,Yongguo Yu
DOI: https://doi.org/10.1016/j.jgg.2021.01.009
IF: 5.723
2021-08-01
Journal of Genetics and Genomics
Abstract:<p>Mitochondrial diseases are caused by variants in both mitochondrial and nuclear genomes. A nuclear gene <em>HPDL</em> (4-hydroxyphenylpyruvate dioxygenase-like), which encodes an intermembrane mitochondrial protein, has been recently implicated to cause a neurodegenerative disease characterized by pediatric-onset spastic movement phenotypes. Here, we report six Chinese patients with bi-allelic <em>HPDL</em> pathogenic variants from four unrelated families showing neuropathic symptoms of variable severity, including developmental delay/intellectual disability, spasm, and hypertonia. Seven different pathogenic variants are identified, of which five are novel. Both fibroblasts and immortalized lymphocytes derived from patients show impaired mitochondrial respiratory function, which is also observed in <em>HPDL</em>-knockdown (KD) HeLa cells. In these HeLa cells, overexpression of a wild-type <em>HPDL</em> gene can rescue the respiratory phenotype of oxygen consumption rate. In addition, a decreased activity of the oxidative phosphorylation (OXPHOS) complex II is observed in patient-derived lymphocytes and <em>HPDL</em>-KD HeLa cells, further supporting an essential role of HPDL in the mitochondrial respiratory chain. Collectively, our data expand the clinical and mutational spectra of this mitochondrial neuropathy and further delineate the possible disease mechanism involving the impairment of the OXPHOS complex II activity due to the bi-allelic inactivations of HPDL.</p>
genetics & heredity,biochemistry & molecular biology